Company Background Xenetic Biosciences, Inc. is a biopharmaceutical company. The Company provides expertise in the development of a whole new generation of drugs, cancer therapies and vaccines. The Company is also developing its own pipeline of next generation biotherapeutics-based on its PolyXen, Oncohist and ImuXen platform technologies. The Company's technologies include PolyXen for protein drug delivery, ImuXen for vaccine delivery and Oncohist. The Company's biopharmaceutical pipeline contains a range of product candidates. Its Pipeline products are based on its drug and vaccine delivery technologies and have been developed to offer improved performance and delivery characteristics.